Royal Bank of Canada
GLMD icon

Royal Bank of Canada’s Galmed Pharmaceuticals GLMD Stock Holding History

Royal Bank of Canada’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$3K – 7748
2021
Q3 		$3K Buy
+6
New +$3.15K ﹤0.01% 7264
2017
Q2 		– Hold
0
– – – 6630
2017
Q1 		– Hold
0
– – – 6676
2015
Q4 		– Sell
-18
Closed -$24K – 6711
2015
Q3 		$24K Buy
+18
New +$29.6K ﹤0.01% 5489
2014
Q3 		– Hold
0
– -$1K – 6030
2014
Q2 		– Hold
0
– – – 5808

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's GLMD Position: Q4 2021 in Review

Royal Bank of Canada sold out of Galmed Pharmaceuticals (GLMD) in Q4 2021, closing a stake of 6 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in GLMD in Q3 2015 and held it in 2 quarters. The position peaked at $24K in Q3 2015. 24 funds tracked by Wall St. Rank hold GLMD as of Q4 2021.

  • Royal Bank of Canada reported no remaining Galmed Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 6 Galmed Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Royal Bank of Canada first reported a position in Galmed Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Royal Bank of Canada's Galmed Pharmaceuticals position peaked at $24K in Q3 2015.
  • 24 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2021.

Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.